![Xi Chen Lin](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Patrimonio netto: 4 M $ in data 30/06/2026
Dr. Xi Chen Lin is a Chief Scientific Officer & GM-Structure Shanghai at Structure Therapeutics, Inc. and a General Manager at Shanghai ShouTi Biotechnology Co. Ltd. Dr. Lin was previously employed as a Head-Asia Pacific External Innovation by Novo Nordisk A/S.
He received his undergraduate degree from Peking University and a doctorate degree from The Pennsylvania State University.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 04/08/2026 | 228.960 ( 0,16% ) | 4 M $ | 30/06/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| STRUCTURE THERAPEUTICS INC. | Direttore Tecnico/Scientifico/R&S | 01/07/2019 |
Shanghai ShouTi Biotechnology Co., Ltd.
 Shanghai ShouTi Biotechnology Co., Ltd. BiotechnologyHealth Technology Develops biotechnologies | Amministratore Delegato | - |
| Società | Posizione | Fine |
|---|---|---|
| NOVO NORDISK A/S | Corporate Officer/Principal | 01/07/2019 |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 5 |
|---|---|
Novo Nordisk A/S
 Novo Nordisk A/S Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products for diabetes care | Health Technology |
Peking University
 Peking University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Pennsylvania State University
 The Pennsylvania State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Structure Therapeutics, Inc.
 Structure Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops molecule therapeutics to treat chronic diseases | Health Technology |
Shanghai ShouTi Biotechnology Co., Ltd.
Shanghai ShouTi Biotechnology Co., Ltd. BiotechnologyHealth Technology Develops biotechnologies | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale
